Canadian Journal of Physiology and Pharmacology

Agonistic autoantibodies directed against the angiotensin II AT₁ receptor in patients with preeclampsia
pp. 79-83(5)
Authors: Wallukat G.; Neichel D.; Nissen E.; Homuth V.; Luft F.C.

Prevention of myosin-induced autoimmune myocarditis in mice by anti-L₃T₄ monoclonal antibody
pp. 84-88(5)
Authors: Liao Y-H.; Wang Z.; Dong J-H.; Cao L-S.; Wang Z-H.; Wang J-P.; Fu M.L.X.; Yuan H-T.

Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?
pp. 89-94(6)
Authors: Zukowska Z.; Pons J.; Lee E.W.; Li L.

Both endothelin-A and endothelin-B receptors are present on adult rat cardiac ventricular myocytes
pp. 95-104(10)
Authors: Phuong L.L.; Farhat H.; Chevalier D.; Allen B.G.

Increased endothelin-1 and endothelin receptor expression in myocytes of ischemic and reperfused rat hearts and ventricular myocytes exposed to ischemic conditions and its inhibition by nitric oxide generation
pp. 105-113(9)
Authors: Gan X.T.; Chakrabarti S.; Karmazyn M.

Cyclooxygenase-2 (COX-2) in acute myocardial infarction: cellular expression and use of selective COX-2 inhibitor
pp. 114-119(6)
Authors: Saito T.; Rodger I.W.; Shennib H.; Hu F.; Tayara L.; Giaid A.

Isradipine prevents the development of spontaneously occurring cardiac necrosis in cardiomyopathic hamster
pp. 120-124(5)
Authors: Jacques D.; Bkaily G.; Jasmin G.; D'Orléans-Juste P.; Chahine M.

Effect of human urotensin-II infusion on hemodynamics and cardiac function
pp. 125-128(4)
Authors: Chouiali F.; Saito T.; Hu F.; Douglas S.A.; Ao Z.; Willette R.N.; Ohlstein E.H.; Giaid A.; Hassan G.S.

Biophysical characteristics of a new mutation on the KCNQ1 potassium channel (L251P) causing long QT syndrome
pp. 129-134(6)
Authors: Deschênes D.; Acharfi S.; Pouliot V.; Hegele R.; Krahn A.; Daleau P.; Chahine M.

Modulation of L-type Ca²⁺ channels in neonatal rat heart by a novel Ca²⁺ channel agonist
pp. 135-141(7)
Authors: Chahine M.; Sculptoreanu A.; Varma D.R.

Regulation of insulin-like growth factor-1 by the renin–angiotensin system during regression of cardiac eccentric hypertrophy through angiotensin-converting enzyme inhibitor and AT₁ antagonist
pp. 142-149(8)
Authors: Blackwell K.; Bikhazi A.; Haddad G.E.

Angiotensin-II-induced enhanced expression of Gi proteins is attenuated by losartan in A10 vascular smooth muscle cells: role of AT₁ receptors
pp. 150-158(9)
Authors: Palaparti A.; Anand-Srivastava M.B.

Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation
pp. 159-167(9)
Authors: Touyz R.M.; Cruzado M.; Tabet F.; Yao G.; Salomon S.; Schiffrin E.L.

Effect of antihypertensive treatment on small artery remodeling in hypertension
pp. 168-176(9)
Author: Schiffrin E.L.

Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the -adrenergic system
pp. 177-185(9)
Authors: Pons J.; Kitlinska J.; Ji H.; Lee E.W.; Zukowska Z.

Pharmacological characterization of putative ₁-₂-adrenergic receptor heterodimers
pp. 186-195(10)
Authors: Lavoie C.; Hébert T.E.

Nuclear prostaglandin signaling system: biogenesis and actions via heptahelical receptors
pp. 196-204(9)
Authors: Gobeil Jr. F.; Vazquez-Tello A.; Marrache A.M.; Bhattacharya M.; Checchin D.; Bkaily G.; Lachapelle P.; Ribeiro-Da-Silva A.; Chemtob S.